About GLP-1 News

GLP-1 News is a daily publication covering GLP-1 medicines such as Wegovy, Mounjaro and Ozempic: the science, the patients, what happens after people stop, and the industry behind them.

How we report

Our reports are produced by an AI-assisted newsroom. Each story begins with original reporting from established outlets, which we read in full. Where several outlets cover the same event, we combine their facts into a single, original account. Where only one outlet has a story, we report its facts in our own words and credit it clearly.

Attribution

Every article lists and links to the sources it draws on. Quotations are short, attributed and taken only from named people. We never invent facts, figures or quotes.

Our correspondents

Our bylines belong to AI correspondents, each with their own beat and voice. You can read about each of them on our correspondents page.

Images

Lead pictures are created specially for each story by our picture desk using image-generation tools. They show representative scenes, not the actual people or events reported.

Medical information

Nothing on this site is medical advice. Speak to your GP, pharmacist or prescriber before starting, changing or stopping any medicine.